Composición farmacéutica para prevenir o tratar la degeneración macular que contiene extracto de mezcla natural como ingrediente activo

Una composición farmacéutica para su uso en la prevención o el tratamiento de la degeneración macular, que contiene un ingrediente activo que consiste en un extracto de una mezcla de ramita de canela y corteza de raíz de peonía, o ramita de canela y raíz de peonía. The extract of a mixture of cinnam...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, Chan-Sik, PYUN, Bo-Jeong, KIM, Junghyun, CHOI, Sojin, LEE, Ik Soo, KIM, Young Sook, SHON, Eunjin, LEE, Yun Mi, JUNG, Dong Ho, JUNG, Seung-Hyun, KIM, Jin Sook
Format Patent
LanguageSpanish
Published 15.10.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Una composición farmacéutica para su uso en la prevención o el tratamiento de la degeneración macular, que contiene un ingrediente activo que consiste en un extracto de una mezcla de ramita de canela y corteza de raíz de peonía, o ramita de canela y raíz de peonía. The extract of a mixture of cinnamon twig and moutan root bark, cinnamon twig and peony root, or cinnamon twig and poria according to the present invention has been confirmed to inhibit the excessive generation of advanced glycation end-products, which occurs under chronic diabetic conditions, exhibit the effect of fragmentizing a cross-link between the advanced glycation end-products and matrix proteins, have an excellent effect in inhibiting the generation of the advanced glycation end-products in a human retinal pigment epithelial cell line subjected to a hyperglycemic or aging environment, and have excellent effects in delaying, preventing, and treating diabetic complications, muscular degeneration, commotio retinae, and lower extremity edema in various animal models of diabetic complications, macular degeneration, and lower extremity edema, and thus the mixture extract can effectively be used as an active ingredient for a composition for preventing and treating diabetic complications, including diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy, and angioedema, including macular (retinal) edema, macular degeneration, and varicose veins.
Bibliography:Application Number: ES20150796502T